APA

Helbig L., Koi L., Brüchner K., Gurtner K., Hess-Stumpp H., Unterschemmann K., Baumann M., Zips D. & Yaromina A. (20150511). BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. : Radiation oncology (London, England).

Chicago

Helbig Linda, Koi Lydia, Brüchner Kerstin, Gurtner Kristin, Hess-Stumpp Holger, Unterschemmann Kerstin, Baumann Michael, Zips Daniel and Yaromina Ala. 20150511. BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. : Radiation oncology (London, England).

Harvard

Helbig L., Koi L., Brüchner K., Gurtner K., Hess-Stumpp H., Unterschemmann K., Baumann M., Zips D. and Yaromina A. (20150511). BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. : Radiation oncology (London, England).

MLA

Helbig Linda, Koi Lydia, Brüchner Kerstin, Gurtner Kristin, Hess-Stumpp Holger, Unterschemmann Kerstin, Baumann Michael, Zips Daniel and Yaromina Ala. BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. : Radiation oncology (London, England). 20150511.